Effects of hormonal contraceptives on mood and brain activity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how oral hormonal contraceptives influence brain processes related to reward and emotional wellbeing in adult females. Participants will be randomly assigned to receive either the contraceptive pill or a placebo for 21 days, during which they will complete daily surveys and undergo functional magnetic resonance imaging (fMRI) to assess neural activity. The study aims to evaluate changes in mood, sexual function, and brain responses to pleasurable stimuli. By understanding these effects, the research seeks to provide insights into the psychological and neurological impacts of hormonal contraceptive use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Aged 18 and older;
2. Right-handed;
3. Assigned female at birth;
4. Regular 21-35 day menstrual cycles for the past 6 months per self-report;
5. In generally good health per self-report. Those with a chronic medical condition may participate at the discretion of the principal investigator if the condition is stable;
6. Willingness to abstain from intercourse or use a non-hormonal back-up method of contraception (e.g., condoms) during the entire course of the study;
7. Negative urine drug screen, excepting marijuana or benzodiazepine that is being prescribed by a physician as a sleep aid, assessed at the baseline visit;
8. Ability to abstain from caffeine and/or cannabis for 2 hours prior to functional Magnetic Resonance Imaging (fMRI) scan visits;
9. Access to a reliable internet connection or cell phone data to complete daily questionnaires;
10. For those wishing to complete study screening session remotely: access to a reliable internet connection, computer to complete electronic consent and a private space to complete the session.

Exclusion Criteria:

1. Presence or history of severe or unstable physical, neurological (per health history interview) or psychiatric disorders (assessed by Miniature International Neuropsychiatric Interview (MINI) but per Diagnostic and Statistical Manual of Mental Disorders - fifth edition (DSM-V) criteria, and the discretion of the principal investigator);
2. Lifetime history of psychotic disorders;
3. History of substance use disorder that has not been in remission (as defined by a substance free period of at least one year). However, individuals with mild disorders, disorders solely limited to cannabis, and/or those who have achieved close to one year of remission may be eligible at the discretion of the PI;
4. Presence or history of any category 3 or 4 conditions or medications per the CDC's (Centers for Disease Control and Prevention) Medical Eligibility Criteria for Contraceptive Use pertaining to combined hormonal contraceptive methods as per self-report and reviewed by the principal investigator;
5. Irregular menstrual periods per self-report;
6. Any current tobacco smoking (former smokers are eligible so long as their quit date was greater than one year ago);
7. Any personal or family history of a venous thromboembolism;
8. Known diagnosis of hypertensive disorder;
9. Any current or past history of malignancy;
10. Migraines with aura;
11. Systolic blood pressure greater than or equal to 140 or diastolic pressure greater than or equal to 90 taken at baseline visit;
12. Currently nursing an infant;
13. Known chromosomal or hormonal disorder affecting sex steroids;
14. Use of hormonal contraceptives currently or in the past 3 months, or use of medications that directly affect sex hormones (i.e. gonadotropin releasing hormone agonists, selective estrogen receptor modifiers);
15. Current pregnancy or pregnancy/delivery in the past six months;
16. Intention to become pregnant during study participation;
17. Current use of psychotropic medication;
18. Claustrophobia;
19. Metal in body unsafe for magnetic resonance imaging;
20. Weight over 300 pounds;
21. Conditions that would make magnetic resonance imaging unsafe for participants (i.e. aneurysm clip, cardiac pacemaker, etc.).

Where it's running

• University of Colorado Denver Anschutz Medical Campus
  Aurora, Colorado, United States Recruiting

Study contacts

• Principal investigator: Andrew M Novick, MD PhD — University of Colorado Denver Anschutz Medical Campus
• Study coordinator: Andrew M Novick, MD PhD
• Email: andrew.m.novick@cuanschutz.edu
• Phone: 2672593730

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of Tyrosol and Creatine on Exercise Performance and Mood

  This study tests whether creatine, tyrosol, or both can improve endurance, strength, and mood in healthy adults over 8 weeks.

  Recruiting Applied Science & Performance Institute · Tampa, Florida · NCT07756658

• BabaCare: Testing a Care Copilot for lonely older adults

  A new AI voice and text companion called Baba is being tested to see if it can help reduce loneliness and improve mood in older adults who live alone.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07689526

• Morning Bright Light for Better Daytime Functioning in University Students

  This study tests whether a one-week, morning 30-minute bright light session improves sleep quality and daytime alertness and mood in healthy university students.

  Recruiting The Hong Kong Polytechnic University · Hung Hom · NCT07685262

• Personalized binaural and spatial music to help with dementia-related symptoms

  This study tests whether personalized binaural beat music, spatialized music, or both can help reduce behavioral and mood symptoms in older adults with dementia or age-related changes living in assisted living facilities.

  Recruiting at 2 sites Maharishi International University · Denver, Colorado and 1 other locations · NCT07626944

• Psilocybin with or without Pimavanserin Pretreatment in Healthy Adults

  This study tests whether a single 25 mg dose of psilocybin, given with or without pimavanserin pretreatment or placebo, affects mood and well-being in healthy adults over one month.

  Recruiting Phase 1/2 Johns Hopkins University · Baltimore, Maryland · NCT07610135

• Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?

  A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.

  Recruiting King's College London · London, London · NCT07599930

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.